| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A classification of the fibrin network structures formed from the hereditary dysfibrinogens
|
SUGO, T.
|
|
2006
|
4 |
8 |
p. 1738-1746
|
artikel
|
| 2 |
Announcements
|
|
|
2006
|
4 |
8 |
p. 1852
|
artikel
|
| 3 |
A novel functional role for the highly conserved α-subunit KVGFFKR motif distinct from integrin αIIbβ3 activation processes
|
AYLWARD, K.
|
|
2006
|
4 |
8 |
p. 1804-1812
|
artikel
|
| 4 |
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancer
|
SIMONNEAU, G.
|
|
2006
|
4 |
8 |
p. 1693-1700
|
artikel
|
| 5 |
A review of upper extremity deep vein thrombosis in pregnancy: unmasking the ‘ART’ behind the clot
|
CHAN, W.-S.
|
|
2006
|
4 |
8 |
p. 1673-1677
|
artikel
|
| 6 |
Artificial reproductive technology and the risk of venous thromboembolic disease
|
NELSON, S. M.
|
|
2006
|
4 |
8 |
p. 1661-1663
|
artikel
|
| 7 |
CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression
|
OISHI, K.
|
|
2006
|
4 |
8 |
p. 1774-1780
|
artikel
|
| 8 |
Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients
|
NELSON, E. J. R.
|
|
2006
|
4 |
8 |
p. 1730-1737
|
artikel
|
| 9 |
DNA microarray analysis for the detection of mutations in hemophilia A
|
BERBER, E.
|
|
2006
|
4 |
8 |
p. 1756-1762
|
artikel
|
| 10 |
Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide
|
PALUMBO, A.
|
|
2006
|
4 |
8 |
p. 1842-1845
|
artikel
|
| 11 |
Enoxaparin vs. nadroparin for venous thromboembolism prevention: too close to tell?
|
TOSETTO, A.
|
|
2006
|
4 |
8 |
p. 1691-1692
|
artikel
|
| 12 |
Forthcoming articles in the September issue
|
|
|
2006
|
4 |
8 |
p. x
|
artikel
|
| 13 |
Gentamicin induces sub-therapeutic levels of coagulation factor VII in patients with nonsense mutations
|
PINOTTI, M.
|
|
2006
|
4 |
8 |
p. 1828-1830
|
artikel
|
| 14 |
Immunologic quantitation of tissue factors
|
PARHAMI-SEREN, B.
|
|
2006
|
4 |
8 |
p. 1747-1755
|
artikel
|
| 15 |
Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo
|
SHELAT, S. G.
|
|
2006
|
4 |
8 |
p. 1707-1717
|
artikel
|
| 16 |
In search for a receptor for antiphospholipid antibodies on target cells
|
PIERANGELI, S. S.
|
|
2006
|
4 |
8 |
p. 1678-1679
|
artikel
|
| 17 |
Interaction of β2-glycoprotein I with members of the low density lipoprotein receptor family
|
PENNINGS, M. T. T.
|
|
2006
|
4 |
8 |
p. 1680-1690
|
artikel
|
| 18 |
Intermittent mechanical compression for prevention of travellers’ thrombosis
|
COPPENS, M.
|
|
2006
|
4 |
8 |
p. 1836-1838
|
artikel
|
| 19 |
Lipopolysaccharide-induced decreased protein S expression in liver cells is mediated by MEK/ERK signaling and NFκB activation: involvement of membrane-bound CD14 and toll-like receptor-4
|
HAYASHI, T.
|
|
2006
|
4 |
8 |
p. 1763-1773
|
artikel
|
| 20 |
Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records
|
OSMAN, A.
|
|
2006
|
4 |
8 |
p. 1723-1729
|
artikel
|
| 21 |
Management of patients with refractory immune thrombocytopenic purpura
|
GEORGE, J. N.
|
|
2006
|
4 |
8 |
p. 1664-1672
|
artikel
|
| 22 |
Marjorie Zucker, PhD, 1919–2006
|
KARPATKIN, S.
|
|
2006
|
4 |
8 |
p. 1847-1848
|
artikel
|
| 23 |
Opposite circadian rhythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation?
|
DAHM, A.
|
|
2006
|
4 |
8 |
p. 1840-1842
|
artikel
|
| 24 |
Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function: a rebuttal
|
KRATZER, M. A. A.
|
|
2006
|
4 |
8 |
p. 1845-1846
|
artikel
|
| 25 |
Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT)
|
GIONA, F.
|
|
2006
|
4 |
8 |
p. 1831-1833
|
artikel
|
| 26 |
Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case–control approach
|
HEGENER, H. H.
|
|
2006
|
4 |
8 |
p. 1718-1722
|
artikel
|
| 27 |
Talking about…
|
BRUTTOMESSO, G.
|
|
2006
|
4 |
8 |
p. 1849-1851
|
artikel
|
| 28 |
The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-κB activation
|
KASTL, S. P.
|
|
2006
|
4 |
8 |
p. 1790-1797
|
artikel
|
| 29 |
The differential association of conjugated equine estrogen and esterified estrogen with activated protein C resistance in postmenopausal women
|
SMITH, N. L.
|
|
2006
|
4 |
8 |
p. 1701-1706
|
artikel
|
| 30 |
The 4G/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin
|
RONCAL, C.
|
|
2006
|
4 |
8 |
p. 1798-1803
|
artikel
|
| 31 |
The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis
|
VAN DE WOUWER, M.
|
|
2006
|
4 |
8 |
p. 1813-1824
|
artikel
|
| 32 |
Thrombin generation in severely obese children
|
CIMENTI, C.
|
|
2006
|
4 |
8 |
p. 1834-1836
|
artikel
|
| 33 |
Thromboprophylaxis with graduated compression stockings for elderly inpatients: more evidence is needed
|
LABARERE, J.
|
|
2006
|
4 |
8 |
p. 1838-1840
|
artikel
|
| 34 |
TNF-α mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-κB- and p38 MAPK-dependent
|
ULFHAMMER, E.
|
|
2006
|
4 |
8 |
p. 1781-1789
|
artikel
|
| 35 |
Travels with fibrinogen
|
BLOMBÄCK, B.
|
|
2006
|
4 |
8 |
p. 1653-1660
|
artikel
|
Tijdschrift beschrijving